Polyclonal Rabbit anti‑Human HSF2 Antibody (370‑450 aa, C‑terminal, IHC, WB) LS‑C384022
Polyclonal Rabbit anti‑Human HSF2 Antibody (370‑450 aa, C‑terminal, IHC, WB) LS‑C384022
Antibody:
HSF2 Rabbit anti-Human Polyclonal (370-450 aa, C-terminal) Antibody
Application:
IHC, WB, ELISA
Reactivity:
Human, Mouse, Rat
Format:
Unconjugated, Unmodified
Overview
Antibody:
HSF2 Rabbit anti-Human Polyclonal (370-450 aa, C-terminal) Antibody
Application:
IHC, WB, ELISA
Reactivity:
Human, Mouse, Rat
Format:
Unconjugated, Unmodified
Specifications
Description
HSF2 antibody LS-C384022 is an unconjugated rabbit polyclonal antibody to HSF2 (370-450 aa, C-terminal) from human. It is reactive with human, mouse and rat. Validated for ELISA, IHC and WB.
Target
Human HSF2
Synonyms
HSF2 | HSTF 2 | Heat shock factor protein 2 | HSF 2 | HSTF2
Reactivity
Human, Mouse, Rat
(tested or 100% immunogen sequence identity)
Conjugations
Unconjugated
Purification
Immunoaffinity purified
Immunogen
Synthesized peptide derived from human HSF2
Epitope
370-450 aa, C-terminal
Specificity
HSF2 Polyclonal Antibody detects endogenous levels of HSF2 protein.
Applications
- IHC (1:100 - 1:300)
- Western blot (1:500 - 1:2000)
- ELISA (1:20000)
|
Performing IHC? See our complete line of Immunohistochemistry Reagents including antigen retrieval solutions, blocking agents
ABC Detection Kits and polymers, biotinylated secondary antibodies, substrates and more.
|
Presentation
PBS, 0.02% Sodium Azide, 50% Glycerol, 0.5% BSA
Storage
Store at -20°C. Avoid freeze-thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Human, Mouse, Rat
Applications:
Immunofluorescence, Western blot, Peptide Enzyme-Linked Immunosorbent Assay
Reactivity:
Human
Range:
0.156-10 ng/ml
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 12/26/2024